Literature DB >> 19200781

Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly.

Frédéric Roche1, Emilia Sforza, Vincent Pichot, Delphine Maudoux, Arnaultd Garcin, Sébastien Celle, Michel Picard-Kossovsky, Jean-Michel Gaspoz, Jean Claude Barthélémy.   

Abstract

BACKGROUND AND
PURPOSE: An association between obstructive sleep apnoea/hypopnea (OSAH) and cardiovascular risk factors such as dyslipidemia has been described in adults and high-risk populations. PATIENTS AND METHODS: We examined this association in a prospective cohort (SYNAPSE study) of 846 elderly (68.5+/-1.1 years) volunteers (41.6% of men). No subject presented with recognized OSAH syndrome, heart disease, or any neurological disorder. Unattended at-home polygraphy was done by all subjects. OSAH severity was defined as moderate (apnoea/hypopnea index: AHI>15/h) or severe (AHI>30/h). High-density lipoprotein cholesterol (HDL-c) was measured by immuno-separation-based homogenous assay.
RESULTS: The prevalence of severe cases reached 21.5% (AHI mean+/-SD: 43.5+/-11.9). Using univariate linear regression analysis, AHI (R=-0.172; p<0.0001), oxyhemoglobin desaturation index (ODI) (R=-0.108; p<0.002), mean SaO(2) (R=0.125; p<0.0003) and Nadir SaO(2) (R=0.094; p<0.007) were significantly associated with HDL-c. Multiple regression analysis demonstrated that male gender, BMI, waist to hip ratio, ODI, and AHI represent independent predictors of HDL-c. Logistic regression analysis showed a significant association between severe OSAH and low HDL-c serum levels (p<0.03) after adjustment for gender, BMI, hypertension, glycaemia, waist to hip ratio, alcohol intake and treated dyslipidemia. The association appears more evident in subjects free of lipid-lowering medications and beta-blockers (p<0.007). There was no independent association of OSAH syndrome with low-density lipoprotein (LDL) cholesterol.
CONCLUSION: Unrecognized moderate to severe apnoea/hypopnea syndrome was independently associated with low HDL-c serum levels in the present cross-sectional based elderly population. This could explain the deleterious effect of OSAH syndrome on cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200781     DOI: 10.1016/j.sleep.2008.07.017

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  29 in total

1.  Pulse transit time in screening sleep disordered breathing in an elderly population: the PROOF-SYNAPSE study.

Authors:  Florian Chouchou; Emilia Sforza; Sébastien Celle; Vincent Pichot; Delphine Maudoux; Arnauld Garcin; Jean Claude Barthélémy; Frédéric Roche
Journal:  Sleep       Date:  2011-08-01       Impact factor: 5.849

2.  Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study.

Authors:  Sarah Rosner Preis; Joseph M Massaro; Udo Hoffmann; Ralph B D'Agostino; Daniel Levy; Sander J Robins; James B Meigs; Ramachandran S Vasan; Christopher J O'Donnell; Caroline S Fox
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

3.  Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance.

Authors:  Alice Liu; James Cardell; Danit Ariel; Cindy Lamendola; Fahim Abbasi; Sun H Kim; Tyson H Holmes; Vanessa Tomasso; Hafasa Mojaddidi; Kaylene Grove; Clete A Kushida; Gerald M Reaven
Journal:  Sleep       Date:  2015-05-01       Impact factor: 5.849

4.  Sleep apnea is related to the atherogenic phenotype, lipoprotein subclass B.

Authors:  Faith S Luyster; Kevin E Kip; Oliver J Drumheller; Thomas B Rice; Daniel Edmundowicz; Karen Matthews; Steven E Reis; Patrick J Strollo
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

5.  Intermittent hypobaric hypoxia promotes atherosclerotic plaque instability in ApoE-deficient mice.

Authors:  Sihua Jiang; Feipeng Jin; De Li; Xingmei Zhang; Yun Yang; Dachun Yang; Kun Li; Yongjian Yang; Shuangtao Ma
Journal:  High Alt Med Biol       Date:  2013-06       Impact factor: 1.981

6.  Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors.

Authors:  Denis Martinez; Cristini Klein; Laura Rahmeier; Roberto Pacheco da Silva; Cintia Zappe Fiori; Cristiane Maria Cassol; Sandro Cadaval Gonçalves; Angelo Jose Goncalves Bos
Journal:  Sleep Breath       Date:  2011-07-28       Impact factor: 2.816

7.  Effects and relationship of intermittent hypoxia on serum lipid levels, hepatic low-density lipoprotein receptor-related protein 1, and hypoxia-inducible factor 1α.

Authors:  Peng Li; Jian Wu; Li Zhao; Xue-Wei Feng
Journal:  Sleep Breath       Date:  2015-06-18       Impact factor: 2.816

8.  Lipid profile after long-term APAP in OSA patients.

Authors:  Sandra Rebelo; Marta Drummond; José Agostinho Marques
Journal:  Sleep Breath       Date:  2014-12-16       Impact factor: 2.816

Review 9.  Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism.

Authors:  Ajibola Monsur Adedayo; Oladipupo Olafiranye; David Smith; Alethea Hill; Ferdinand Zizi; Clinton Brown; Girardin Jean-Louis
Journal:  Sleep Breath       Date:  2012-08-18       Impact factor: 2.816

Review 10.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.